Bullish Moving Averages
3
Bearish Moving Averages
13
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
2116.40Today’s High
2149.8052W low
1661.0052W High
2490.00Open Price
2137.90Prev. Close
2156.3000Volume
333939.00Value
714462490.50Fundamentals
Market Cap Cr
85715.90
Price to Earnings
44.60
Price to Book Value
9.00
Dividend Yield
0.00
PE to Growth
0.90
Op Revenue TTM Cr
10334.77
Net Profit TTM Cr
1920.21
Cash From Operating Activity Cr
2152.44
Return on Equity %
20.43
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
03 Jul, 2024
68.4
Week
71.2
Month
68.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
2135.22
PIVOT
First Resistance
2154.08
Second Resistance
2168.67
Third Resistance
2187.53
First Support
2120.63
Second Support
2101.77
Third Support
2087.18
Relative Strength Index
45.76
Money Flow Index
39.21
MACD
-10.39
MACD Signal
-6.58
Average True Range
63.05
Average Directional Index
26.39
Rate of Change (21)
0.66
Rate of Change (125)
8.1
Commodity Channel Index
-77.6
Williams %R
-76.7
BETA
1 Month
0.23
3 Month
0.24
1 Year
0.25
3 Year
PRICE CHANGE ANALYSIS
↑ 0.53%
1 Week
Low
High
2096
2169.4
↓ -0.01%
1 Month
Low
High
1931.35
2282.75
↓ -10.61%
3 Months
Low
High
1931.35
2490
↑ 1.53%
6 Months
Low
High
1931.35
2490
↑ 25.35%
1 Year
Low
High
1661.05
2490
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 2236.54 | 2425.80 | 2511.46 | 2357.65 | 1914.58 | 1968.64 | 2326.70 | 2080.03 | 1652.97 | |
| Operating Expenses Qtr | 1605.35 | 1755.46 | 1818.15 | 1760.74 | 1490.96 | 1562.73 | 1735.21 | 1640.87 | 1335.62 | |
| Operating Profit Qtr | 547.33 | 603.11 | 635.19 | 539.47 | 381.16 | 373.50 | 522.34 | 420.39 | 309.20 | |
| EBIDT Qtr Cr | 631.19 | 670.34 | 693.31 | 596.90 | 423.62 | 405.90 | 591.49 | 439.16 | 317.35 | |
| Depreciation Qtr | 82.29 | 89.73 | 77.04 | 68.54 | 67.30 | 71.02 | 66.04 | 65.22 | 36.41 | |
| Net Profit Qtr | 454.17 | 487.07 | 472.88 | 409.28 | 280.99 | 248.87 | 420.23 | 298.16 | 217.48 | |
| Basic EPS Qtr | 11.34 | 12.16 | 11.80 | 10.22 | 7.01 | 6.21 | 10.49 | 7.44 | 5.43 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 9531.45 | 8289.94 | 7419.77 | 5677.68 | 4888.26 | |
| Operating Expenses Annual Cr | 6939.70 | 6429.77 | 5457.42 | 4151.31 | 3550.96 | |
| Operating Profit Annual | 2325.10 | 1697.38 | 1799.61 | 1378.29 | 1243.46 | |
| Operating Profit Margin Annual % | 24.39 | 20.48 | 24.25 | 24.28 | 25.44 | |
| Total Expenses Annual Cr | 7271.88 | 6727.10 | 5622.23 | 4237.47 | 3623.34 | |
| EBIDT Annual Cr | 2591.74 | 1860.16 | 1962.34 | 1526.37 | 1337.31 | |
| EBIDT Annual margin % | 27.19 | 22.44 | 26.45 | 26.88 | 27.36 | |
| Depreciation | 317.61 | 269.58 | 120.98 | 78.19 | 61.77 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1823.41 | 1248.26 | 1335.13 | 1084.37 | 958.23 | |
| Net Profit Annual | 1823.41 | 1248.26 | 1335.13 | 1084.37 | 958.23 | |
| Basic EPS Annual | 45.52 | 31.16 | 33.33 | 27.07 | 23.92 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 9623.81 | 7783.91 | 6068.77 | 4734.27 | 3651.45 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 200.54 | 168.12 | 116.06 | 67.15 | 63.89 | |
| Total Current Liabilities Annual Cr | 1593.36 | 1419.09 | 2228.01 | 1078.91 | 815.77 | |
| Total Capital Plus Liabilities Annual Cr | 11417.71 | 9371.12 | 8412.85 | 5880.33 | 4531.11 | |
| Fixed Assets Annual | 3591.92 | 3637.00 | 3273.08 | 1152.98 | 1092.39 | |
| Total Non Current Assets Annual | 5858.79 | 5854.21 | 5156.07 | 2790.35 | 2582.50 | |
| Total Current Assets Annual | 5558.92 | 3516.91 | 3256.78 | 3089.98 | 1948.60 | |
| Total Assets Annual | 11417.71 | 9371.12 | 8412.85 | 5880.33 | 4531.11 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 168.37 | 275.47 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1982.97 | 1798.99 | 812.29 | 1022.33 | 959.61 | |
| Cash from Investing Activity Annual | -1919.12 | -1040.61 | -1369.34 | -1127.16 | -395.68 | |
| Cash from Financing Annual Activity | -8.68 | -710.41 | 578.92 | 88.87 | -558.91 | |
| Net Cash Flow Annual | - | 47.96 | 21.87 | -15.96 | 5.02 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 240.24 | 194.31 | 151.50 | 118.18 | 91.15 | |
| ROE Annual % | 18.94 | 16.03 | 22.00 | 22.90 | 26.24 | |
| ROCE Annual % | 23.14 | 20.00 | 29.77 | 30.16 | 34.33 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.11 | 0.02 | 0.00 | |
| EBDIT Annual Margin % | 27.97 | 22.88 | 27.04 | 27.60 | 27.89 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 2533.23 | 2677.09 | 2768.08 | 2637.24 | 2100.18 | 2128.07 | 2453.21 | 2196.54 | 1759.29 | |
| Operating Expenses Qtr | 1849.99 | 2000.45 | 2025.45 | 1923.80 | 1635.99 | 1653.89 | 1835.13 | 1723.79 | 1440.93 | |
| Operating Profit Qtr | 591.10 | 606.51 | 682.65 | 654.82 | 416.68 | 437.04 | 590.71 | 456.20 | 284.83 | |
| EBIDT Qtr Cr | 683.23 | 676.64 | 742.62 | 713.43 | 464.19 | 474.18 | 618.09 | 472.74 | 318.36 | |
| Depreciation Qtr | 104.69 | 109.73 | 96.48 | 87.35 | 84.52 | 84.79 | 78.59 | 78.02 | 47.36 | |
| Net Profit Qtr | 471.24 | 453.76 | 501.03 | 494.19 | 285.44 | 284.15 | 419.71 | 292.56 | 190.08 | |
| Basic EPS Qtr | 11.76 | 11.33 | 12.51 | 12.15 | 7.13 | 7.09 | 10.48 | 7.30 | 4.74 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 10615.63 | 8878.00 | 7977.58 | 6385.38 | 5975.65 | |
| Operating Expenses Annual Cr | 7799.70 | 6848.80 | 5792.20 | 4566.33 | 4428.42 | |
| Operating Profit Annual | 2535.07 | 1900.64 | 1989.35 | 1648.10 | 1436.81 | |
| Operating Profit Margin Annual % | 23.88 | 21.41 | 24.94 | 25.81 | 24.04 | |
| Total Expenses Annual Cr | 8231.49 | 7219.18 | 6017.43 | 4705.45 | 4549.45 | |
| EBIDT Annual Cr | 2815.93 | 2029.20 | 2185.38 | 1819.05 | 1547.23 | |
| EBIDT Annual margin % | 26.53 | 22.86 | 27.39 | 28.49 | 25.89 | |
| Depreciation | 398.25 | 325.92 | 166.62 | 118.97 | 99.06 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1926.56 | 1297.25 | 1438.51 | 1281.36 | 1044.61 | |
| Net Profit Annual | 1912.90 | 1281.86 | 1433.47 | 1265.43 | 1030.42 | |
| Basic EPS Annual | 47.75 | 32.00 | 35.78 | 31.59 | 25.72 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 9363.09 | 7435.22 | 6155.23 | 4722.00 | 3485.31 | |
| Minority Interest Liability Annual Cr | 212.70 | 188.07 | 161.08 | 140.89 | 186.26 | |
| Total Non Current Liabilities Annual Cr | 267.74 | 229.02 | 207.96 | 156.34 | 143.13 | |
| Total Current Liabilities Annual Cr | 2119.73 | 1863.14 | 2623.47 | 1353.40 | 1258.59 | |
| Total Capital Plus Liabilities Annual Cr | 11963.25 | 9715.45 | 9147.74 | 6372.63 | 5073.28 | |
| Fixed Assets Annual | 4807.04 | 4780.78 | 4269.22 | 2015.95 | 1896.11 | |
| Total Non Current Assets Annual | 5313.04 | 5387.58 | 4740.92 | 2465.99 | 2251.07 | |
| Total Current Assets Annual | 6650.21 | 4327.87 | 4406.82 | 3906.64 | 2822.22 | |
| Total Assets Annual | 11963.25 | 9715.45 | 9147.74 | 6372.63 | 5073.28 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 167.78 | 211.93 | 183.16 | 88.52 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 2152.45 | 1813.30 | 919.78 | 1137.24 | 1069.70 | |
| Cash from Investing Activity Annual | -2081.69 | -1054.13 | -1369.14 | -1222.21 | -439.15 | |
| Cash from Financing Annual Activity | 5.27 | -739.73 | 604.62 | -7.81 | -530.74 | |
| Net Cash Flow Annual | - | 19.44 | 155.25 | -92.78 | 99.81 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 239.04 | 190.30 | 157.68 | 121.39 | 91.65 | |
| ROE Annual % | 20.43 | 17.24 | 23.28 | 26.79 | 29.56 | |
| ROCE Annual % | 24.56 | 21.69 | 30.94 | 33.87 | 37.96 | |
| Total Debt to Total Equity Annual | 0.02 | 0.02 | 0.14 | 0.05 | 0.04 | |
| EBDIT Annual Margin % | 27.24 | 23.19 | 28.08 | 29.27 | 26.37 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ICICI PRUDENTIAL MUTUAL FUND | 1.6 | 73806612 | - | - |
| AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND | 1.54 | 73806613 | - | - |
| SBI NIFTY MIDCAP 150 INDEX FUND | 1.52 | 73806614 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sheetal Arora | 4.81 | 73806524 | 0 | 0 |
| Puja Juneja | 2.88 | 73806525 | 0 | 0 |
| Poonam Juneja | 2.64 | 73806526 | 0 | 0 |
| Arjun Juneja | 2.04 | 73806527 | 0 | 0 |
| Ramesh Juneja | 1.71 | 73806528 | 0 | 0 |
| Rajeev Juneja | 1.62 | 73806529 | 0 | 0 |
| Chanakya Juneja | 0.97 | 73806530 | 0 | 0 |
| Eklavya Juneja | 0.97 | 73806531 | 0 | 0 |
| Mishka Arora | 0.74 | 73806532 | 0 | 0 |
| Ramesh Juneja Family Trust (Held in the name of Ramesh Juneja, Managing Trustee) | 20.81 | 73806555 | 0 | 35.56 |
| Rajeev Juneja Family Trust (Held in the name of Rajeev Juneja, Managing Trustee) | 19.95 | 73806556 | 0 | 35.08 |
| Prem Sheetal Family Trust (Held in the name of Arora Family Private Limited, Trustee) | 15.42 | 73806557 | 0 | 36.33 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ICICI PRUDENTIAL MUTUAL FUND | 1.6 | 73806612 |
| AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUND | 1.54 | 73806613 |
| SBI NIFTY MIDCAP 150 INDEX FUND | 1.52 | 73806614 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HEMA CIPEF (I) LIMITED | 2.22 | 73806626 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 15, 2024 | Audited Results & Others | To evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. |
| Jan 31, 2024 | Quarterly Results | - |
| Oct 31, 2023 | Quarterly Results | - |
| Aug 02, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
03 Jul 2024
Mankind Pharma front-runner to buy Bharat Serums, binding bids yet to be submitted
From a 52-week low of 1,661.05 in July 2023, the company's shares rose to a high of 2,490 in April 2024, though it has come off those highs now
26 Jun 2024
Mankind Pharma Ltd - 543904 - Closure of Trading Window
Closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s ''Code of Conduct for Prohibition of Insider Trading''
18 Jun 2024
Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Result of Postal Ballot under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 and Report of Scrutinizer Pursuant to section 108 & 110 of the Companies Act 2013 and rules made thereunder.
18 Jun 2024
Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Voting Result of Postal Ballot under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Report of Scrutinizer Pursuant to Section 108 & 110 of the Companies Act, 2013 and Rules made thereunder.
13 Jun 2024
Mankind Pharma - Disruptor With A Dose Of Care; Motilal Oswal Initiates Coverage With A Buy
Focus on chronic therapies to support growth
07 Jun 2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement in respect of Scheme of Arrangement for Amalgamation of Shree Jee Laboratory Private Limited, JPR Labs Private Limited and Jaspack Industries Private Limited ("Transferor Companies") with Mankind Pharma Limited ("Transferee Company"/"The Company") under Section 230-232 of the Companies Act, 2013 ("Scheme"/"Scheme of Amalgamation")
03 Jun 2024
Mankind Pharma Ltd - 543904 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
29 May 2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of participation in Investor Conference
22 May 2024
Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Investor Conference Call for Q4FY24 - Transcript 
